Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 316

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 316
---
 for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point -of-carediagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non -pharmaceuticalproducts, including nutritional and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third -partyveterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. 155

The following is a table including details regarding the industry, size, and profitability along with further detail regarding revenue forecasts and the specific multiples considered for each Guideline Company:

| (in $ Millions)                                
 Company Name Industry                          |     | Abbott        
 Laboratories  
 Pharmaceutica |           |   |     | AdaptHealth 
 Corp.       
 Health Care |         |   |     | DarioHealth 
 Corp.       
 Health Care |        |    |     | DexCom, Inc. 
 Health Care  |          |   |     | Insulet     
 Corporation 
 Health Care |          |   |     | Medtronic plc 
 Health Care   |           |   |     | Senseonics     
 Holdings, Inc. 
 Health Care    |        |    |     | Diabetes   
 Care, Inc. 
 Health     
 Care       |         |    |     | Zoetis Inc.   
 Pharmaceutica |          |   |     |  25th % |     |  Median |
|:-----------------------------------------------|:----|:--------------|----------:|:--|:----|:------------|--------:|:--|:----|:------------|-------:|:---|:----|:-------------|---------:|:--|:----|:------------|---------:|:--|:----|:--------------|----------:|:--|:----|:---------------|-------:|:---|:----|:-----------|--------:|:---|:----|:--------------|---------:|:--|:----|--------:|:----|--------:|
| Enterprise Value                               |     | $             | 176,330.0